Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma

NCT04402138

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Tulane University, Office of Clinical Research New Orleans, Louisiana, United States
  • HCA Midwest Kansas City, Missouri, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

NCT00179673

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Alta Bates Cancer Center Berkeley, California, United States
  • Pacific Coast Hematology/Oncology Medical Group, Onc. Fountain Valley, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma

NCT03295240

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Accuracy Performance Verification of the INVOS™ System in Pediatrics

NCT05962905

Conditions
Cerebral Oxygenation, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Children's Mercy Kansas City Kansas City, Missouri, United States
  • Washington University St. Louis St Louis, Missouri, United States
  • Duke University Durham, North Carolina, United States
  • Cleveland Clinic Children's Cleveland, Ohio, United States
View Trial Details
Completed

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT03158688

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Medical Center - Multiple Myeloma Research Consortium Chicago, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View all 113 locations
View Trial Details
Completed

PRIMARY TESTICULAR LYMPHOMA

NCT06964841

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Instituto Mexicano del Seguro Social Mérida, Yucatán, Mexico
View Trial Details
Completed

Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

NCT04034056

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Ospedale Civile Dello Spirito Santo Pescara, Abruzzo, Italy
  • AOU Policlinico Consorziale Bari, Apulia, Italy
  • Giovanni Paolo II/I.R.C.C.S. Istituto Tumori Bari, Apulia, Italy
  • Asl Bat Ospedale Mons. Dimiccoli Barletta, Apulia, Italy
View all 46 locations
View Trial Details
Completed

Collecting and Storing Tissue From Young Patients With Cancer

NCT00898755

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, +47 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details

Related conditions